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Novel implantable and externally controllable bio-nanomachines-
based treatment strategies for Glioblastoma brain cancer have been
proposed recently to bring hope to patients who suffer from this
devastating cancer type. The main challenges in developing such
strategies lie in both crossing the stringent Blood-Brain Barrier
and maximizing the drug concentration at particular sites rich in
Glioblastoma cells within safety guidelines. Aiming to provide a
first step towards the realization of such a novel treatment method,
here we propose analytical models to characterize and analyze an
exosome-mediated brain drug delivery molecular communication
system. We consider biophysical models and derive the closed-form
transfer functions for a communication system that comprises of
the engineered neural stem cells that release exosomes into the
extracellular space in the brain and Glioblastoma-like cells that
collect exosomes from the extracellular space in the brain. The
presented numerical results show a dependency of the exosome
propagation on various hindrance sources in the extracellular space
and a limited operation performance at high frequencies that refer
to the exosome concentration dynamics. The collection of exosomes
by Glioblastoma-like cells show a dependency on high and stable
exosome concentration in the extracellular space and low-frequency
operation for a reasonable performance output.
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1 INTRODUCTION
Glioblastoma Multiforme is the most prevalent and devastating
brain disease whose treatment have the lowest success rates com-
pared to other therapeutic cancer technologies [9]. The develop-
ment of brain drug delivery systems for this type of cancer is very
challenging because of side effects, the complexity of the struc-
tures of the brain, and the stringent Blood-Brain Barrier (BBB) that
protects the brain from damage and potentially toxic blood-borne
molecules. In addition, the lack of efficient technologies to deliver
drugs in the deep located and functional brain regions, such as the
brain parenchyma, and across the BBB hinders treatment of brain
pathologies [2, 13, 14]. Hence, novel technologies for Glioblastoma
cancer therapy must emerge to overcome the BBB blockage while
efficiently reaching the brain parenchyma within safety guidelines.
An externally controllablemolecular communicationplat-
form that consists of stem cells acting as therapeutic, reporting
and diagnostic bio-nanomachines has been proposed in the recently
granted EU project GLADIATOR: Next-generation Theranostics of
Brain Pathologies with Autonomous Externally Controllable Nanonet-
works: a Trans-disciplinary Approach with Bio-nanodevice Interfaces
(EU-H2020-FET-Open #828837). The therapeutic bio-nanomachines
are autologous organoids of engineered induced Reprogramming
Neural Stem Cells (iR-NSCs) implanted into the brain parenchyma
to synthesize and release rationally designed therapeutic molecules.
The iR-NSCs are controlled by external miniature wearable devices
via in-messaging communication channels. Therapeutic molecules
collaboratively interfere with the underlying disease pathways in
the target Glioblastoma cells. We envision that this proposed tech-
nology can overcome the challenges imposed by the BBB and reach
the brain parenchyma for the treatment of Glioblastoma cancer.
Therapeutic molecules also collaboratively interfere with another
type of bio-nanomachines, that we call reporting bio-nanomachines.
The reporting bio-nanomachines are engineered Glioblastoma Stem
















Figure 1: Block diagram of the brain tumour management
platform as a fully autonomous externally controllable
molecular communication network.
Cells (GSCs) that serve as the gateway for communicating the effi-
cacy of the treatment. Ultimately, the diagnostic bio-nanomachines
are engineered induced Monitoring Neural Stem Cells (iM-NSCs)
that collect and analyze reporting molecules. The iM-NSCs serve
as ‘sensors’ of the hybrid implantable diagnostic system which
provides feedback to external miniature wearable devices via out-
messaging communication channels. External wearable devices
with enabling communication interfaces, iR-NSCs, GSCs, and iM-
NSCs form a radically new closed-loop platform for the manage-
ment of brain malignancies shown in Fig. 1, and provide a break-
through theranostic (therapeutic + diagnostic) intervention.
A promising strategy for iR-NSCs and GSCs is to use exosomes
as cargos to deliver, respectively, therapeutic and reportingmolecules
to their recipients. Exosomes are 40 − 100 nm cell-derived extra-
cellular vesicles that are released from cells upon fusion of an in-
termediate endocytic compartment, called the multivesicular body,
with the plasma membrane [10]. Exosomes play an important role
in cell-to-cell signaling containing transmembrane proteins in their
lipid bilayer and the cytosol molecular components from their pro-
genitor cell including functional proteins, genetic lipids, genetic
materials like messenger RNA (mRNA), microRNA (miRNA), short
interfering RNA (siRNA), and genomic DNA (gDNA) [5]. Upon
fusion with the target cell, exosomes deliver the transmembrane
proteins and biologically active molecules. Due to their biological
tolerability, natural targeting, and phagocytosis-inhibition factors,
exosomes have been recently regarded as one of the most promis-
ing opportunities to deliver chemical packages to the target cell,
while protecting the packages from enzymes circulating in body
fluids [17]. Hence, exosomes pose as the main information carrier to
deliver reactive drugmolecules to Glioblastoma cells within a poten-
tial therapeutic solution termed as an exosome-mediated drug
delivery system [2]. On top of that, theMolecular Communication
(MC) ([1]) paradigm becomes the natural choice to characterize,
monitor and control the communication system between iR-NSCs,
GSCs, and iM-NSCs.
In this paper, we propose an analytical model of the exosome-
mediated brain drug delivery MC system for analyzing the
communication between iR-NSCs and GSCs. By developing an
analytical model that characterizes the propagation and reception
of the exosomes in the brain parenchyma, we aim to address the
quantification of the exosome concentration delivery based on spa-
tial, temporal and frequency analysis. To this end, the considered
MC system model encompasses the iR-NSC abstracted as an MC
transmitter, the brain extracellular space abstracted as an MC chan-
nel, and the GSC abstracted as a (reactive)MC receiver, as illustrated
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Figure 2: The considered MC systemmodel. iR-NSC is an in-
duced Reprogramming Neural Stem Cell. GSC is a Glioblas-
toma Stem Cell.
in Fig. 2. Upon reception of external signals, the MC transmitter
releases the exosomes with a particular rate through the process
called exocytosis. The exosomes then propagate/diffuse through
the extracellular space in the brain parenchyma. The exosomes
that gather around the MC receiver bind to the surface of the cell
through the process called endocytosis.
Although the MC paradigm has been recently proposed to model
particulate drug delivery systems [6–8, 11], the existing models do
not yield analytical expressions that can be of practical use to model
the exosome-mediated brain drug delivery system which has many
challenges for maximizing the exosome delivery at cancerous sites.
Maximizing the exosome delivery refers to the design and engineer-
ing of the exosome structure, mode and location of administration
and dosage optimization from iR-NSCs and GSCs. Being themain fo-
cus of this paper, proper analytical models of the exosome-mediated
MC system and its quantitative analysis are much needed as the
first step towards the development of the envisioned Glioblastoma
treatment. The contributions are as follows:
• We develop a biophysical analytical model considering the
unique targeting properties of exosomes, the unique proper-
ties of the brain extracellular space like volume fraction and
tortuosity, and the unique exosome uptake mechanism in a
form of receptor-mediated endocytosis.
• We derive closed-form solutions for transfer functions of
both the channel and receiver, which allow us to conduct a
frequency analysis of each module. More specifically, we ap-
ply the Fourier transform to the simplified diffusion equation
solution in the extracellular space of the brain to derive the
channel transfer function; we apply the multi-dimensional
Fourier transform and the single-input Volterra series to
derive higher order transfer functions for the non-linear
endocytosis process at the receiver.
2 THE EXOSOME-MEDIATED BRAIN DRUG
DELIVERY MC SYSTEM MODEL
The system model located in the brain parenchyma comprises of
the one-directional communication system between iR-NSCs (trans-
mitter) and GSCs (receiver) where exosomes serve as information
carriers to deliver engineered payload from the IR-NSCs propa-
gating to the brain extracellular matrix (channel). This process is
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depicted in Fig. 2. In the next subsections, we define communica-
tion modules from a biophysical perspective that leads to a more
detailed description of the functioning and relationship between
them.
2.1 Transmitter
The exosome emission by the iR-NSCs involves the process of exocy-
tosis wheremultivesicular bodies are excreted from the intracellular-
to the extracellular environment. The exocytosis is extremely com-
plex involving numerous intracellular signaling reactions. In this
paper, however, we focus on extracellular signaling pathways be-
tween bio-nanomachines and exclude the transmitter modeling
at this stage. Instead, we consider the result of exocytosis as a
fixed excreted concentration of exosomes, ce0 (t0, x0) = Q , where
x0 = (x0,y0, z0) denotes the location of the transmitting iR-NSC.
2.2 Channel
The extracellular matrix of the brain is a space where a number of
molecules diffuse propagating metabolic information among cells,
whether they are neurons or non-neurons. Two main properties
of the extracellular matrix in the brain dictate the propagation of
molecules, namely volume fraction and tortuosity [21]. We explore
these two properties to analyze a channel model for the exosome
propagation. We use both volume fraction and tortuosity to gener-
ate a model of anisotropic exosome diffusion.
The volume fraction determines a percentage of the total tissue
volume accessible to the exosomes. Formally, it is defined as
α = VExtracellular Matrix/VTissue (1)
where VExtracellular Matrix denotes the volume of the extracellular
matrix andVTissue denotes the volume of the whole tissue measure
in a small region of the brain. Typically, α can be measured using
real-time iontophoresis cation tetramethylammonium (RTI-TMA).
Typical values are: 0.1 ≤ α ≤ 0.3. Free diffusion medium such as
aqueous solutions or very dilute gel can consider α = 1.
The tortuosity describes the average hindrance of a complex
medium relative to an obstacle-free medium. The hindrance results
in an effective diffusion which is decreased compared with the free
diffusion coefficient of exosomes,D. In neurobiological applications,




where D∗ is the effective diffusivity of exosomes in the brain ex-
tracellular matrix. For an impenetrable medium λ = ∞; for an
obstacle-free medium λ = 1. The tortuosity of the brain extracel-
lular matrix is approximately constant with λ ≈ 1.6. Owing to (2),
this means that the exosomes in the brain parenchyma have the
effective diffusion coefficient reduced by a factor of ∼2.6 compared
with D.
We consider ce (t ,x) as the concentration of exosomes in the
extracellular matrix as a function of both time t and location x =
(x ,y, z). Based on the detailed work in [21], we consider the follow-
ing diffusion equation:





∇2ce (t , x) +
ce0 (t0, x0)






−v∇ce (t , x)︸      ︷︷      ︸
bulk flow
. (3)
The complicated boundary conditions associated with the intercel-
lular clefts have been replaced by the parameters λ and α through
the introduction of averaged variables. In (3), the ‘diffusion’ term
represents the propagation of the exosomes, in which the effective
diffusion coefficient is defined via tortuosity. The ‘uptake’ term rep-
resents the losses or clearances of material from the extracellular
matrix (e.g., into cells, across the BBB, or degradation through enzy-
matic attack). The f (ce (t , x)) term represents the Michaelis-Menten
update with f (ce (t , x)) = −k ′αce (t , x), where k ′ is a first order
scalar defined as k ′ = ασk , where σ is the ratio of the total sur-
faces withinVTissue to the extracellular volumeVExtracellular Matrix.
Either k ′ or k can be obtained through experimental curve fitting
approaches [16]. Ultimately, the ‘bulk flow’ term represents the
guiding force upon the exosomes, which is simplified to a generic
terms with the velocity vector v and the subsequent scalar product
with the concentration gradient ∇ce (t , x).
Aiming to account for brain tissue anisotropic properties, (3)
is modified by considering the tortuosity as a set of three distinct
second-order components, which is possible when considering a
natural set of rectangular Cartesian coordinates. Then, we consider
the following diffusion equation:





















f (ce (t , x))
α
− v∇ce (t , x). (4)
If a signal pulse duration has a value of tp , the solution yields by
solving (4) due to the linear nature of the diffusion equations and
its solutions (see [21]):
ce =
{
ce (t) if t ≤ tp ,
ce (t) − ce (t − tp ) if t > tp ,
(5)
with













































2λ2z andu(t) is the Heaviside function.
Assuming k ′ = 0 and an isotropic propagation where λx = λy =
λz = λ, R = rλ and r =
√
x2 + y2 + z2, (6) simplifies as:












The adhesion of exosomes to the recipient cell utilizes the interac-
tion of various exosomal surface proteins and cellular receptors [15].
Three main mechanisms provide the uptake of exosomes once they
bound to the target cell: 1) juxtacrine signaling – where the exo-
somes elicit transduction via intracellular signaling pathways, 2)
fusion – where the exosomes fuse with the cellular membrane and
transfer cargo into the cytoplasm, and (iii) endocytosis – where
the exosomes internalize and retain in transport vesicles either via
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phagocytosis, macropinocytosis or receptor-mediated endocyto-
sis. Receptor-mediated endocytosis is a specific pattern of partic-
ular relevance for the targeted drug delivery systems that reduce
the nondiscriminate uptake of exosomes and enhances exosome
accumulation at the target site. Receptor-mediated endocytosis
takes advantage of differential expression of receptors between
disease-affected and normal tissues allowing for a rapid ligand-
targeted internalization and controlled intracellular trafficking [22].
For example, the exosomes taken up by clathrin-dependent receptor-
mediated endocytosis are typically destined for lysosomal degrada-
tion, unlike clathrin-independent receptor-mediated endocytosis
that leads to endosomal accumulation and nondegradation [3]. The
general process of receptor-mediated endocytosis is well under-
stood in the literature and involves a sequence of well-orchestrated
mechanisms [12, 23]. In this subsection, we develop the exosome
reception model by GSCs from the chemical kinetic model based on
a system of ordinary differential equations which describe the tem-
poral evolution of spatially-averaged concentrations of exosomes.
The first step in receptor-mediated endocytosis illustrated in
Fig. 3 involves the exosome binding to the target GSC selective
receptors in specialized regions of the membrane formed from a
protein called clathrin. Clathrin can form lattice-like coats destined
for trafficking [19]. The corresponding membrane regions used
for endocytosis are accordingly refered to as clathrin-coated pits.
Upon binding to clathrin-coated pits, the exosomes become internal-
ized into the GSC cytosol forming endosomes. Recycling/negative
feedback mechanisms regulate the number of GSC surface bonds
between the exosomes and receptors, leading to the following chem-
ical kinetic model representing the concentration of the exosomes
in the brain extracellular matrix ce (t), the concentration of bound
exosomes cb (t), and the concentration of internalized exosomes in




=βke − ace (t) [pmN (t) + pmN0(t) − cb (t)] (8)
dcb (t)
dt
=ace (t) [pmN (t) + pmN0(t) − cb (t)] − kicb (t) (9)
dcr (t)
dt
=kicb (t) − kdcr (t), (10)
where β is the ratio of the volume of the considered extracellular
medium containing ce and the GSC volume, ke is the rate at which
the exosomes are supplied to the considered extracellular medium
containing ce , pm is the total number of the exosomes that can
be bound in the clathrin-coathed pits, N (t) is the total number of
occupied clathrin-coathed pits per unit volume at the membrane,
N0(t) is the total number of unoccupied clathrin-coathed pits per
unit volume at themembrane,a = a0/pm is the rate defined through
the maximal binding rate a0 measured when none of the exosomes
is bound to the membrane, ki is the exosome internalization rate,
and kd is the exosome degradation rate.
3 TRANSFER FUNCTION REPRESENTATION
OF THE SYSTEM
3.1 Channel Transfer Function
If a point-source in both space and time is considered where volume













Figure 3: Endocytosis in glioblastoma stem cells.
function solution to (4) follows as [21]:













Assuming k ′ = 0 and an isotropic propagation, (11) simplifies as:

















ce (t , xr )exp(−jωt)dt , (13)
where xr = (xr ,yr , zr ) denotes the location of the receiving GSC.
This integral is of special form whose solution follows from the













































the modified Bessel function of the second kind (also known as the
MacDonald function). By combining (12), (13), and (14), we derive
the brain extracellular space channel transfer function as:




















where I1/4(x) and I−1/4(x) are the modified Bessel functions of the
first kind. We omit detailed derivation due to the page limit.
3.2 Receiver Transfer Function
Combining (8)-(10), we can derive the receiver transfer function
with the input to the receiver restricted to follow dynamics defined
by (8). However, excluding (8) from the derivation imposes more
complicated analysis but offers complete freedom with the input to
the receiver. Considering ce (t , xr ) as the input of the receiver, where
xr = (xr ,yr , zr ) denotes the location of the receiving GSC, ensures
a concatenation of the channel and receiver transfer functions in
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(b) Block diagram for serial combination of Volterra system and linear system.
Figure 4: Block diagram for cascaded model of endocytosis.
an end-to-end channel analysis that is a natural extension of this
work. Thereby, we derive the receiver transfer function from (9)
and (10) in what follows.
Eq. (9) that represents dynamics of the concentration of bound
exosomes can be simplified by assuming that sum of the total num-
ber of occupied clathrin-coated pits per unit volume and the total
number of unoccupied clathrin-coated pits per unit volume is con-
stant, i.e., N (t) + N0(t) = N̄ , where N̄ represents the total number
of clathrin-coated pits. This is a valid assumption due to receptor
dynamics at the membrane [23]. Even though, Eq. (9) remains a
non-linear differential equation. Accordingly, the corresponding
system H (1)r in Fig. 4(a) is non-linear.
The single-input Volterra series is well established as a powerful
tool in the analysis of non-linear systems [24]. The Volterra series
is a generalization of the well-known input-output relation for lin-
ear systems, with h1(τ ), h2(τ1,τ2), h3(τ1,τ2,τ3), . . . , hn (τ1, . . . ,τn )
representing generalizations of the linear impulse response func-
tion called Volterra kernels. The higher order transfer functions
or Volterra kernel transforms Hn (jω1, . . . , jωn ), n = 1, . . . ,∞ are
defined as the multi-dimensional Fourier transforms. Hence, the
following equations apply:





hn (τ1, . . . ,τn )×
exp (−j (ω1τ1 + · · · + ωnτn )) dτ1 . . . dτn (17)







Hn (jω1, . . . , jωn )×
exp (j (ω1τ1 + · · · + ωnτn )) dω1 . . . dωn . (18)
Aiming to determine the analytical form of kernel transforms
that we introduce to describeH (1)r , i.e., h
(1)
r1 (τ ), . . . , h
(1)
rn (τ1, . . . ,τn ),
we apply the method of harmonic probing [4]. In this method,
the system is excited by ce (t) = exp (jω1t) to obtain the first or-
der transfer function H (1)r1 (jω1), ce (t) = exp (jω1t) + exp (jω2t) to
obtain the second order transfer function H (1)r2 (jω1, jω2), ce (t) =
exp (jω1t)+exp (jω2t)+exp (jω3t) to obtain the third order transfer
function H (1)r3 (jω1, jω2, jω3), etc., as follows:
H
(1)












r1 (jω1) + H
(1)
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nth -order Volterra kernel h(1)rn (τ1, . . . ,τn ) follows by combining (22)
and (18).
Eq. (10) that represents dynamics of the concentration of inter-
nalized exosomes in the GSC cytosol is linear. Accordingly, the
corresponding linear systemH (2)r in Fig. 4(a) can be described with







The impulse response h(2)r (t) directly follows as:
h
(2)







= kiexp (−kd t)u(t). (24)
The overall transfer function of endocytosis in the target GSC
now follows from H (1)rn (jω1, . . . , jωn ) given with (22) and H
(2)
r (jω)
given with (23), by applying the interconnection cascade law of
Volterra series as [20]:
Hrn (jω1, . . . , jωn ) = H
(1)
rn (jω1, . . . , jωn )H
(2)
r (jω1+ · · ·+ jωn ), (25)
as shown in Fig. 4(b). The overall impulse response of endocytosis
in the target GSC follows by combining (25) and (18) as:







Hrn (jω1, . . . , jωn )×
exp (j (ω1τ1 + · · · + ωnτn )) dω1 . . . dωn . (26)
Ultimately, the output endosome concentration follows as Volterra
series which express the output of the nonlinear system in “powers"











dτnhr (τ1, . . . ,τn )
n∏
m=1
ce (t − τm ).
(27)
Note that the first-order kernel hr (τ1) is the familiar impulse re-
sponse of a linear system. The higher order kernels viewed as higher
order impulse responses serve to characterize the various orders of
nonlinearity in endocytosis.
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(a) Temporal evaluation of exosomes con-
centrations versus tortuosity variation.







(b) Distance evaluation of exosomes con-
centrations versus tortuosity variation.
Figure 5: The effect of tortuosity on the exosome propaga-
tion. The tortuosity variability is gathered from the experi-
ments in [21].
4 NUMERICAL RESULTS
In this section, we present numerical results in terms of the exo-
some concentration dynamics, and magnitude and phase for both
channel and receiver modules. Since the presented model imposes
specific limitations with respect to the whole brain physiological
organization and neglect additional interference or noise sources,
we provide some remarks about the analysis as follows.
We assume the tortuosity values are known as stationary values.
Even though this is true for low t values, tortuosity should be
considered as a random variable. For simplicity, we do not include
this analysis at this stage.
The channel module is computed by (7) and depicted in Fig. 5(a)
and Fig. 5(b). The concentration of exosomes shows a distinct ex-
ponential behavior between the temporal and the spatial analysis.
By using an initial concentration of Q = 100 molecules/ml, α = 0.2
and D = 15 µm2/s, we observe a continuous increase of exosomes
over time with fixed receiver at 1 µm apart. The accumulative exo-
some concentration is different among tortuosity values with the
exponential incremental relation leading to a variation of 4 − 6.4
molecules/ml. From Fig. 5(a), we infer that higher tortuosity values
impose lower loss of the propagating exosomes. From Fig. 5(b),
we observe that the concentration of exosomes dramatically de-
creases with distance increase, converging to near-zero values. This
imposes a high impact of molecular diffusion loss in micro-scales
in the brain. Even with different tortuosity values, we observe a
marginally noticeable difference at t = 1 s. This difference might
be significant in large time-scales, potentially more applicable dur-
ing drug-delivery settings. Since bio-nanomachines are capable of
differentiating molecules at very small values, we are looking at an
operating range between 0.1 − 1 µm of distance.
The receiver module is computed by (9)-(10) and (27) and de-
picted in Fig. 6(a) and Fig. 6(b). By using a = 6.64 × 10−17 mole-
cule/mol/sec, N = 180, pm = 200, ki = 0.0027 1/s, kd = 0.0002 1/s
and ce (t) = 1.17 × 1013 molecule/ml [23], we observe an increase
over time of cb (t) and cr (t). In particular, while approximately keep-
ing values of cb (t) = 1×104, we obtain the increase rate of 8.5×108
molecules/ml/second. This result tells that the reception process
based on cr (t) can be increasingly effective if high concentrations of
ce (t) are maintained at stable levels. This is increasingly challenging
at realistic settings, but highlights the importance of more complex
transmitter designs (not considered in this paper). Ultimately, from


















(a) Temporal evaluation of the exosome
concentrations based on Eqs. (9–10).










(b) The internalized exosome concentra-
tions based on Eqs. (10) and (27).
Figure 6: Temporal evaluations of the exosome concentra-











































Figure 7: Bode diagram of the channel transfer function
He (jω) versus tortuosity variation.
Fig. 6(b) we are able to observe a very good match between a solu-
tion of (10) and (27) using n = 3 Volterra kernels, which indicates
the correctness of the analytical approach presented in Section 3.2.
For the frequency analysis, we use the closed-form expressions
obtained in (15) and (25) to visualize the corresponding Bode plots.
We depict the results in Fig. 7 and Fig. 8. The frequency analysis
of the channel module indicates that the effects of tortuosity are
frequency dependent for both magnitude and phase. The magni-
tude drops monotonically for frequencies higher than 100 rad/s,
indicating that transmission in these frequencies should be avoided.
The phase is approx. 0.35 rad and tortuosity independent for fre-
quencies less than 10 rad/s. Both results, however, converge to the
hypothesis that higher levels of tortuosity impact lower operational
frequencies. We can observe that the relationship between tortu-
osity and frequency is favorable to continue with larger tortuosity
values. Since the tortuosity measures the level of channel diffusion
propagation effectiveness, we can predict that lower tortuosity val-
ues will likely have the worst overall communication performance
due to its inability to operate in high frequencies.
The frequency analysis of the receiver module is evaluated based
on the Volterra kernel transforms usingn = 3. The magnitude of the
first-order transfer function Hr1 (jω1) shown in Fig. 8(a), constantly
decreases with the frequency increase, whereas the phase values
change between −π and π . The magnitudes of the second-order

























(a) Magnitude and phase of the linear transfer function
Hr1 (jω1).
(b) Magnitude and phase of the second-order transfer
function Hr2 (jω1, jω2).
(c) Magnitude and phase of the third-order transfer func-
tion Hr3 (jω1, jω2, jω3 = jω0) with ω0 = 2π e−3.
Figure 8: Bode diagrams of the receiver Volterra kernel transforms.
transfer functionHr2 (jω1, jω2) and the third-order transfer function
Hr3 (jω1, jω2, jω3 = jω0) with ω0 = 2π × 10−3 rad/s shown in Fig.
8(b) and Fig. 8(c), respectively, both exhibit very low variability and
approximates values of−450 dB and−700 dB. Based on these results,
the endocytosis perfomed by GSCs shows a very low-frequency
operation for a reasonable performance output.
5 CONCLUSION
In this paper, we developed a communication engineering model
of an exosome-based Molecular Communication (MC) system to
support future treatment strategies for Glioblastoma based on ex-
ternally controlled bio-nanomachines. We present results that show
an analysis of the exosome concentration, and Bode diagrams of
respective modules (channel and receiver) for an MC system com-
prising of bio-nanomachines, i.e., engineered stem-cells that emit
and collect exosomes that serve as drug cargos. The channel (the
extracellular matrix of the brain) shows a dependency on tortuosity
which impacts positively with its increase, and a limited opera-
tion performance at high frequencies. The receiver (an engineered
Glioblastoma stem-cell) shows a dependency on high and stable ex-
osome concentration and low-frequency operation for a reasonable
performance output.
Based on the presented models, we foresee continued theoretical
developments for maximization of the transmission of exosomes
by bio-nanomachines in the brain to control the progression of
Glioblastoma and impact negatively in the cancerous cells activity
using MC principles. In this way, we believe that these novel mod-
els can create better and optimized drug delivery systems based
on exosomes by using the newly formed MC knowledge that has
been impacting on biotechnology for a number of years now, and
continually redefining medicine treatment strategies as we know.
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